CatalystPit

ALLOAllogene Therapeutics, Inc.

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $1.60 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$552.79M
RECENT INSIDER TRADES
  • 2026-08-25 · Douglas Earl Martin (SVP, General Counsel) · SELL
  • 2026-04-23 · Yoshiyama Annie (SVP, Finance) · SELL
  • 2026-04-02 · Beneski Benjamin Machinas (SVP, Chief Technical Officer) · SELL
  • 2026-03-18 · Chang David D (President and CEO) · SELL
  • 2026-03-18 · Beneski Benjamin Machinas (SVP, Chief Technical Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders225
Shares held344,356,804
Value$692.21M
Percent of shares outstanding99.67%
As of quarter end2026-06-30
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Allogene Therapeutics, Inc. (ALLO) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit